公开(公告)号：US20070259883A1

公开(公告)日：2007-11-08

申请号：US11569575

申请日：2005-02-02

申请人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zheng ,  Hongying Liu ,  Yunde Xie ,  Wu Zhong ,  Hao Cui

发明人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zheng ,  Hongying Liu ,  Yunde Xie ,  Wu Zhong ,  Hao Cui

IPC分类号： A61K31/497 ,  C07D263/30 ,  C07D413/02

CPC分类号： C07D263/32

摘要： The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia

摘要翻译： 本发明涉及式I化合物，外消旋体，旋光异构体或其药学上可接受的盐或溶剂合物，以及包含该化合物的药物组合物，式I中的各种基团与权利要求中所定义相同。 本发明还涉及制备式I化合物的方法，以及所述化合物在制备用于治疗高血糖，血脂异常，II型糖尿病的药物中的用途，所述II型糖尿病包括相关的糖尿病性血脂异常

公开(公告)号：US07781468B2

公开(公告)日：2010-08-24

申请号：US11597656

申请日：2005-03-02

申请人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zhen ,  Hongying Liu ,  Yunde Xie ,  Zhong Wu ,  Hao Cui

发明人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zhen ,  Hongying Liu ,  Yunde Xie ,  Zhong Wu ,  Hao Cui

IPC分类号： A61K31/421 ,  C07D263/30

CPC分类号： C07D263/32 ,  C07D413/12

摘要： The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia

摘要翻译： 本发明涉及式I化合物，外消旋体，旋光异构体或其药学上可接受的盐或溶剂合物，以及包含该化合物的药物组合物，式I中的各种基团与权利要求中所定义相同。 本发明还涉及制备式I化合物的方法，以及所述化合物在制备用于治疗高血糖，血脂异常，II型糖尿病的药物中的用途，所述II型糖尿病包括相关的糖尿病性血脂异常

公开(公告)号：US07544687B2

公开(公告)日：2009-06-09

申请号：US11569575

申请日：2005-02-02

申请人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zheng ,  Hongying Liu ,  Yunde Xie ,  Wu Zhong ,  Hao Cui

发明人： Song Li ,  Xinbo Zhou ,  Lili Wang ,  Cheng Xu ,  Chengmai Ruan ,  Cuifang Lin ,  Junhai Xiao ,  Zhibing Zheng ,  Hongying Liu ,  Yunde Xie ,  Wu Zhong ,  Hao Cui

IPC分类号： A61K31/496 ,  C07D263/32

CPC分类号： C07D263/32

摘要： The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia.

摘要翻译： 本发明涉及式I化合物，外消旋体，旋光异构体或其药学上可接受的盐或溶剂合物，以及包含该化合物的药物组合物，式I中的各种基团与权利要求中所定义相同。 本发明还涉及制备式I化合物的方法和所述化合物在制备用于治疗高血糖，血脂异常，II型糖尿病，包括相关糖尿病性血脂异常的药物中的应用。